Three Distinct Phases of HIV-1 RNA Decay in Treatment-Naive Patients Receiving Raltegravir-Based Antiretroviral Therapy: ACTG A5248-Reference-Cited by-同舟云学术

Three Distinct Phases of HIV-1 RNA Decay in Treatment-Naive Patients Receiving Raltegravir-Based Antiretroviral Therapy: ACTG A5248

Published:2013-06-24 Issue:6 Volume:208 Page:884-891
ISSN:1537-6613
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Andrade Adriana¹,Rosenkranz Susan L.²,Cillo Anthony R.³,Lu Darlene²,Daar Eric S.⁴,Jacobson Jeffrey M.⁵,Lederman Michael⁶,Acosta Edward P.⁷,Campbell Thomas⁸,Feinberg Judith⁹,Flexner Charles¹,Mellors John W.³,Kuritzkes Daniel R.¹⁰,

Affiliation:

1. The Johns Hopkins University, Baltimore, Maryland

2. Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Massachusetts

3. University of Pittsburg Medical Center, Pennsylvania

4. Los Angeles Biomedical Research Institute at Harbor UCLA, Torrance, California

5. Drexel University College of Medicine, Philadelphia, Pennsylvania

6. Case Western Reserve University, Cleveland, Ohio

7. University of Alabama at Birmingham

8. University of Colorado Hospital, Aurora, Colorado

9. University of Cincinnati Medical Center, Ohio

10. Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts

Publisher